Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 2010

Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
Institute of Internal Medicine, Catholic University, Largo F. Vito 1, 00186 Rome, Italy. pconti@unich.it

In recent years, the field of primary immunodeficienciency diseases (PID) has experienced remarkable progress with the identification of a number of new genes associated with specific diseases. Yet the diagnosis of PID remains difficult. In fact, this field requires continuous updating because once a novel molecule related to the immune function is discovered, the corresponding PID will soon be described. Since comprehensive reviews on the classification of PID are available, we concentrate here on reviewing some controversial and new issues, mainly those related to the role of T-cells and innate immunity. We will consider common variable immunodeficiency as an example of a PID where several immune pathways are impaired. We will also discuss the restricted usage of the T-cell receptor repertoire in PID. Innate immunity and Toll-like receptors (TLR) are new major players in this field. We will therefore discuss the association of TLR with the function of Bruton tyrosine kinase (Btk) that is essential in the development of B-cells and in the pathogenesis of X-linked agammaglobulinemia. Finally, we will discuss the role of mast-cells. These cells were once thought to be relevant almost exclusively to the pathogenesis of allergy. Now we know that mast cells are involved in initiating the adaptive response and may contribute to ineffective immune responses.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
January 1985, The Turkish journal of pediatrics,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
January 2009, Arerugi = [Allergy],
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
December 2002, Current molecular medicine,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
January 2006, Ernst Schering Research Foundation workshop,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
January 2005, Journal of autoimmunity,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
March 2019, Journal of neurochemistry,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
August 2018, Thrombosis and haemostasis,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
April 2024, Immunity,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
April 2008, Current opinion in allergy and clinical immunology,
Franco Pandolfi, and Rossella Cianci, and Giovanni Cammarota, and Danilo Pagliari, and Raffaele Landolfi, and Pio Conti, and Theoharis C Theoharides
January 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
Copied contents to your clipboard!